BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Morales BP, Planas R, Bartoli R, Morillas RM, Sala M, Casas I, Armengol C, Masnou H. HEPACONTROL. A program that reduces early readmissions, mortality at 60 days, and healthcare costs in decompensated cirrhosis. Dig Liver Dis. 2018;50:76-83. [PMID: 28870446 DOI: 10.1016/j.dld.2017.08.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Bloom PP, Ventoso M, Tapper E, Ha J, Richter JM. A Telemonitoring Intervention for Cirrhotic Ascites Management Is Cost-Saving. Dig Dis Sci 2021. [PMID: 34018070 DOI: 10.1007/s10620-021-07013-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Serigado JM, Barboza KC, Marcus P, Sigal SH. Clinical Impact of Depression in Cirrhosis. Curr Hepatology Rep 2018;17:22-32. [DOI: 10.1007/s11901-018-0386-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Ames JB, Djerboua M, Terrault NA, Booth CM, Flemming JA, Peltekian KM. Rising Healthcare Costs and Utilization among Young Adults with Cirrhosis in Ontario: A Population-Based Study. Canadian Journal of Gastroenterology and Hepatology 2022;2022:1-13. [DOI: 10.1155/2022/6175913] [Reference Citation Analysis]
4 Ebhohon E, Ogundipe OA, Adejumo AC. Alarming rate of 30-day hospital readmissions in patients with liver cirrhosis. Ann Transl Med 2021;9:1608. [PMID: 34926652 DOI: 10.21037/atm-21-5258] [Reference Citation Analysis]
5 Bloom PP, Marx M, Wang TJ, Green B, Ha J, Bay C, Chung RT, Richter JM. Attitudes towards digital health tools for outpatient cirrhosis management in patients with decompensated cirrhosis. BMJ Innov 2020;6:18-25. [DOI: 10.1136/bmjinnov-2019-000369] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
6 Sobotka LA, Modi RM, Vijayaraman A, Hanje AJ, Michaels AJ, Conteh LF, Hinton A, El-Hinnawi A, Mumtaz K. Paracentesis in cirrhotics is associated with increased risk of 30-day readmission. World J Hepatol 2018; 10(6): 425-432 [PMID: 29988878 DOI: 10.4254/wjh.v10.i6.425] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ignatiev E, Samardzija MK, Paul S, Vuckovic KM, Lockwood MB. Standardized Patient Education for Decompensated Cirrhotic Patients and Impact on Clinician Satisfaction. Gastroenterol Nurs 2021;44:233-9. [PMID: 34176889 DOI: 10.1097/SGA.0000000000000543] [Reference Citation Analysis]
8 Moghe A, Yakovchenko V, Morgan T, McCurdy H, Scott D, Rozenberg-Ben-Dror K, Rogal S. Strategies to Improve Delivery of Cirrhosis Care. Curr Treat Options Gastroenterol 2021;:1-11. [PMID: 34054289 DOI: 10.1007/s11938-021-00345-y] [Reference Citation Analysis]
9 Gaspar R, Rodrigues S, Silva M, Costa-Moreira P, Morais R, Andrade P, Cardoso H, Albuquerque A, Liberal R, Macedo G. Predictive models of mortality and hospital readmission of patients with decompensated liver cirrhosis. Dig Liver Dis 2019;51:1423-9. [PMID: 31113738 DOI: 10.1016/j.dld.2019.03.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
10 Carbonneau M, Davyduke T, Congly SE, Ma MM, Newnham K, Den Heyer V, Tandon P, Abraldes JG. Impact of specialized multidisciplinary care on cirrhosis outcomes and acute care utilization. CanLivJ 2021;4:38-50. [DOI: 10.3138/canlivj-2020-0017] [Reference Citation Analysis]
11 Mah JM, Dewit Y, Groome P, Djerboua M, Booth CM, Flemming JA. Early hospital readmission and survival in patients with cirrhosis: A population-based study. CanLivJ 2019;2:109-20. [DOI: 10.3138/canlivj.2018-0025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
12 Williams R, Alessi C, Alexander G, Allison M, Aspinall R, Batterham RL, Bhala N, Day N, Dhawan A, Drummond C, Ferguson J, Foster G, Gilmore I, Goldacre R, Gordon H, Henn C, Kelly D, MacGilchrist A, McCorry R, McDougall N, Mirza Z, Moriarty K, Newsome P, Pinder R, Roberts S, Rutter H, Ryder S, Samyn M, Severi K, Sheron N, Thorburn D, Verne J, Williams J, Yeoman A. New dimensions for hospital services and early detection of disease: a Review from the Lancet Commission into liver disease in the UK. Lancet 2021;397:1770-80. [PMID: 33714360 DOI: 10.1016/S0140-6736(20)32396-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Hayward KL, Weersink RA. Improving Medication-Related Outcomes in Chronic Liver Disease. Hepatol Commun 2020;4:1562-77. [PMID: 33163829 DOI: 10.1002/hep4.1612] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Orman ES, Ghabril MS, Desai AP, Nephew L, Patidar KR, Gao S, Xu C, Chalasani N. Patient-Reported Outcome Measures Modestly Enhance Prediction of Readmission in Patients with Cirrhosis. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00814-4. [PMID: 34311111 DOI: 10.1016/j.cgh.2021.07.032] [Reference Citation Analysis]
15 Yoder L, Mladenovic A, Pike F, Vuppalanchi R, Hanson H, Corbito L, Desai AP, Chalasani N, Orman ES. Attendance at a Transitional Liver Clinic May Be Associated with Reduced Readmissions for Patients with Liver Disease. Am J Med 2021:S0002-9343(21)00647-1. [PMID: 34655539 DOI: 10.1016/j.amjmed.2021.09.016] [Reference Citation Analysis]